Home › Stocks › RNA › All Fund Holders
RNA — ATRIUM THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 44 · Reported value held: $1.25B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 13.65M | $984.52M | 0.01% | Add |
| Casdin Capital history | Q4 2025 | 1.00M | $72.13M | 4.48% | Reduce |
| Soros Fund Management history | Q4 2025 | 840.98K | $60.66M | 0.79% | New |
| Wellington Management Group history | Q4 2025 | 723.12K | $52.16M | 0.01% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.45M | $19.47M | 0.00% | Add |
| Alkeon Capital Management history | Q2 2022 | 856.47K | $12.45M | 0.04% | Hold |
| Moore Capital Management history | Q3 2021 | 335.40K | $5.89M | 0.09% | New |
| Geode Capital Management history | Q2 2026 | 386.93K | $5.21M | 0.00% | Add |
| Farallon Capital Management history | Q1 2026 | 349.36K | $4.67M | 0.03% | New |
| Two Sigma Investments history | Q2 2026 | 345.48K | $4.65M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 310.34K | $4.17M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 200.56K | $2.70M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 172.24K | $2.32M | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 139.97K | $1.87M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 132.83K | $1.79M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 130.22K | $1.75M | 0.00% | Add |
| Norges Bank Investment Management history | Q2 2026 | 126.58K | $1.70M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 119.78K | $1.61M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 105.88K | $1.42M | 0.00% | Reduce |
| Fidelity International (FIL) history | Q2 2026 | 76.50K | $1.03M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 67.64K | $909.75K | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 62.85K | $845.37K | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 56.70K | $762.60K | 0.00% | New |
| CPP Investments history | Q2 2026 | 41.97K | $564.50K | 0.00% | Hold |
| Morgan Stanley history | Q2 2026 | 41.94K | $564.12K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 39.25K | $527.94K | 0.00% | Reduce |
| Prudential Financial history | Q4 2025 | 7.06K | $509.24K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q3 2025 | 11.58K | $504.41K | 0.00% | Reduce |
| Principal Global Investors history | Q4 2025 | 6.67K | $480.96K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 33.53K | $451.00K | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 33.69K | $450.45K | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2026 | 22.71K | $303.61K | 0.00% | New |
| Amundi US history | Q4 2025 | 3.94K | $284.12K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 19.57K | $263.24K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 17.45K | $234.72K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 14.97K | $201.36K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 14.97K | $201.31K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 14.17K | $190.64K | 0.00% | Add |
| PSP Investments history | Q1 2026 | 12.88K | $172.23K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 9.39K | $128.15K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 6.68K | $89.91K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 1.47M | $19.81K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 1.42K | $19.13K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 594 | $7.99K | 0.00% | Reduce |